1. Home
  2. ZIM vs ADPT Comparison

ZIM vs ADPT Comparison

Compare ZIM & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZIM Integrated Shipping Services Ltd.

ZIM

ZIM Integrated Shipping Services Ltd.

HOLD

Current Price

$24.62

Market Cap

3.0B

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$22.38

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZIM
ADPT
Founded
1945
2009
Country
Israel
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.7B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
ZIM
ADPT
Price
$24.62
$22.38
Analyst Decision
Hold
Strong Buy
Analyst Count
5
9
Target Price
$19.26
$17.78
AVG Volume (30 Days)
1.1M
2.7M
Earning Date
05-20-2026
05-05-2026
Dividend Yield
7.65%
N/A
EPS Growth
N/A
63.89
EPS
N/A
N/A
Revenue
N/A
$276,976,000.00
Revenue This Year
N/A
$3.98
Revenue Next Year
N/A
$22.72
P/E Ratio
$3.49
N/A
Revenue Growth
N/A
54.77
52 Week Low
$12.33
$9.96
52 Week High
$29.97
$23.15

Technical Indicators

Market Signals
Indicator
ZIM
ADPT
Relative Strength Index (RSI) 47.92 61.02
Support Level $23.96 $15.08
Resistance Level $26.16 $22.97
Average True Range (ATR) 0.59 1.26
MACD 0.08 -0.14
Stochastic Oscillator 48.64 80.17

Price Performance

Historical Comparison
ZIM
ADPT

About ZIM ZIM Integrated Shipping Services Ltd.

ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: